A human has received an experimental therapy intended to reverse aging. The treatment, which aims to make cells young again, is being trialled for the first time in a person, with the goal of potentially reversing age-related effects, such as sight loss. The therapy has received clearance and is part of a new approach to aging that involves epigenetic reprogramming.